Experienced in Ewing Sarcoma

Dr. Theodore S. Hong

Radiology
Beth Israel Deaconess Medical Center
Beth Israel Deaconess Medical Center-Needham
148 Chestnut Street, 
Needham, MA 
On Staff At
Clinical Trials:Currently Recruiting for 2 Trials
Offers Telehealth
Experienced in Ewing Sarcoma
Beth Israel Deaconess Medical Center
Beth Israel Deaconess Medical Center-Needham
148 Chestnut Street, 
Needham, MA 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Theodore Hong is a Radiologist in Needham, Massachusetts. Dr. Hong is rated as an Experienced provider by MediFind in the treatment of Ewing Sarcoma. His top areas of expertise are Pancreatic Cancer, Anal Cancer, Cholangiocarcinoma (Bile Duct Cancer), Pancreaticoduodenectomy, and Tissue Biopsy.

His clinical research consists of co-authoring 290 peer reviewed articles and participating in 21 clinical trials. MediFind looks at clinical research from the past 15 years.

Graduate Institution
University Of Connecticut Health Center Campus
Residency
University of Wisconsin Hospitals and Clinics
Specialties
Radiology
Licenses
Radiology in MA
Board Certifications
American Board Of Radiology
Hospital Affiliations
Newton-Wellesley Hospital
Massachusetts General Hospital
Beth Israel Deaconess Medical Center
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
BMC HealthNet
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Cigna
  • EPO
  • HMO
  • PPO
Commonwealth Care Alliance
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Mass General Brigham Health Plan
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • PPO
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Tufts
  • HMO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 8 Less Insurance Carriers -

Locations

Beth Israel Deaconess Medical Center-Needham
148 Chestnut Street, Needham, MA 02492
Call: 781-767-1923
Other Locations
Beth Israel Deaconess Medical Center-Radiation Oncology
330 Brookline Avenue, Fnb25, Boston, MA 02215
Call: 617-667-2345
Winchester Hospital Center for Cancer Care
Center For Cancer Care, 620 Washington St, Winchester, MA 01890
Call: 781-756-8300

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

20 Clinical Trials

A Phase II Study of Neoadjuvant NAPOX Followed by Chemoradiation With Paclitaxel and Carboplatin in Locally Advanced Esophagogastric Cancer
A Phase II Study of Neoadjuvant NAPOX Followed by Chemoradiation With Paclitaxel and Carboplatin in Locally Advanced Esophagogastric Cancer
Enrollment Status: Recruiting
Publish Date: November 14, 2025
Intervention Type: Radiation, Drug
Study Drugs: FOLFOX/ nal-IRI, Paclitaxel, Carboplatin
Study Phase: Phase 2
A Phase III Randomized Trial of Protons Versus Photons for Hepatocellular Carcinoma
A Phase III Randomized Trial of Protons Versus Photons for Hepatocellular Carcinoma
Enrollment Status: Recruiting
Publish Date: November 10, 2025
Intervention Type: Other, Procedure, Radiation
Study Phase: Phase 3
Phase I Trial With Expansion Cohort of OBP-301 (Telomelysin™) and Definitive Chemoradiation for Patients With Locally Advanced Esophageal and Gastroesophageal Cancer Who Are Not Candidates for Surgery
Phase I Trial With Expansion Cohort of OBP-301 (Telomelysin™) and Definitive Chemoradiation for Patients With Locally Advanced Esophageal and Gastroesophageal Cancer Who Are Not Candidates for Surgery
Enrollment Status: Active_not_recruiting
Publish Date: January 30, 2026
Intervention Type: Biological, Drug, Radiation
Study Drugs: Carboplatin, Paclitaxel, Telomerase-specific Type 5 Adenovirus OBP-301
Study Phase: Phase 1
Nivolumab and Ipilimumab and Radiation Therapy in Microsatellite Stable (MSS) and Microsatellite Instability (MSI) High Colorectal and Pancreatic Cancer
Nivolumab and Ipilimumab and Radiation Therapy in Microsatellite Stable (MSS) and Microsatellite Instability (MSI) High Colorectal and Pancreatic Cancer
Enrollment Status: Active_not_recruiting
Publish Date: January 12, 2026
Intervention Type: Drug, Radiation
Study Drugs: Nivolumab, Ipilimumab
Study Phase: Phase 2
PACER (Pancreatic AdenoCarcinoma With Electron Intraoperative Radiation Therapy): A Phase II Study of Electron Beam Intraoperative Radiation Therapy Following Chemoradiation in Patients With Pancreatic Cancer With Vascular Involvement
PACER (Pancreatic AdenoCarcinoma With Electron Intraoperative Radiation Therapy): A Phase II Study of Electron Beam Intraoperative Radiation Therapy Following Chemoradiation in Patients With Pancreatic Cancer With Vascular Involvement
Enrollment Status: Active_not_recruiting
Publish Date: December 09, 2025
Intervention Type: Radiation
Study Phase: Not Applicable
A Pilot Study of FOLFIRINOX in Combination With Neoadjuvant Radiation for Gastric and GE Junction Cancers
A Pilot Study of FOLFIRINOX in Combination With Neoadjuvant Radiation for Gastric and GE Junction Cancers
Enrollment Status: Completed
Publish Date: November 25, 2025
Intervention Type: Drug, Radiation
Study Phase: Phase 1
Phase Ib/II Study of TAS-102 Plus Radiation Therapy for the Treatment of the Liver in Patients With Hepatic Metastases From Colorectal Cancer
Phase Ib/II Study of TAS-102 Plus Radiation Therapy for the Treatment of the Liver in Patients With Hepatic Metastases From Colorectal Cancer
Enrollment Status: Active_not_recruiting
Publish Date: October 21, 2025
Intervention Type: Radiation, Drug
Study Drug: TAS-102
Study Phase: Phase 1/Phase 2
A Randomized Phase 2 Study of Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer
A Randomized Phase 2 Study of Losartan and Nivolumab in Combination With FOLFIRINOX and SBRT in Localized Pancreatic Cancer
Enrollment Status: Active_not_recruiting
Publish Date: October 01, 2025
Intervention Type: Drug, Radiation, Procedure
Study Drugs: FOLFIRINOX, Losartan, Nivolumab
Study Phase: Phase 2
Phase II Study of Individualized Stereotactic Body Radiotherapy of Liver Metastases
Phase II Study of Individualized Stereotactic Body Radiotherapy of Liver Metastases
Enrollment Status: Completed
Publish Date: September 30, 2025
Intervention Type: Radiation
Study Phase: Not Applicable
Phase II Study of Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer and Cholangiocarcinoma
Phase II Study of Proton Beam Irradiation for the Treatment of Unresectable Hepatocellular Cancer and Cholangiocarcinoma
Enrollment Status: Completed
Publish Date: September 15, 2025
Intervention Type: Radiation
Study Phase: Not Applicable
A Pilot Feasibility Study of Definitive Concurrent Chemoradiation With Pencil Beam Scanning Proton Beam in Combination With 5-Fluorouracil and Mitomycin-C for Carcinoma of the Anal Canal
A Pilot Feasibility Study of Definitive Concurrent Chemoradiation With Pencil Beam Scanning Proton Beam in Combination With 5-Fluorouracil and Mitomycin-C for Carcinoma of the Anal Canal
Enrollment Status: Completed
Publish Date: September 05, 2025
Intervention Type: Drug, Radiation
Study Drugs: 5-fluorouracil, Mitomycin-C
Study Phase: Early Phase 1
A Phase II Study of Niraparib and Dostarlimab With Radiation in Patients With Metastatic Pancreatic Cancer
A Phase II Study of Niraparib and Dostarlimab With Radiation in Patients With Metastatic Pancreatic Cancer
Enrollment Status: Completed
Publish Date: August 15, 2025
Intervention Type: Drug, Radiation
Study Drugs: Niraparib, Dostarlimab
Study Phase: Phase 2
Nivolumab and Ipilimumab and Radiation Therapy in Metastatic, Microsatellite Stable Pancreatic Cancer
Nivolumab and Ipilimumab and Radiation Therapy in Metastatic, Microsatellite Stable Pancreatic Cancer
Enrollment Status: Active_not_recruiting
Publish Date: September 08, 2022
Intervention Type: Drug, Radiation
Study Drugs: Nivolumab, Ipilimumab
Study Phase: Phase 2
Nivolumab and Ipilimumab and Radiation Therapy in Metastatic, Microsatellite Stable Colorectal Cancer
Nivolumab and Ipilimumab and Radiation Therapy in Metastatic, Microsatellite Stable Colorectal Cancer
Enrollment Status: Unknown
Publish Date: September 08, 2022
Intervention Type: Drug, Radiation
Study Phase: Phase 2
An Open-Label Multicenter Phase 1b Study of E7046 in Combination With Radiotherapy/Chemoradiotherapy (RT/CRT) in Preoperative Treatment of Subjects With Rectum Cancer
An Open-Label Multicenter Phase 1b Study of E7046 in Combination With Radiotherapy/Chemoradiotherapy (RT/CRT) in Preoperative Treatment of Subjects With Rectum Cancer
Enrollment Status: Completed
Publish Date: October 04, 2021
Intervention Type: Radiation, Drug
Study Phase: Phase 1
Phase II Study of Preoperative FOLFIRINOX Followed by Accelerated Short Course Radiation Therapy for Borderline-Resectable Pancreatic Cancer
Phase II Study of Preoperative FOLFIRINOX Followed by Accelerated Short Course Radiation Therapy for Borderline-Resectable Pancreatic Cancer
Enrollment Status: Unknown
Publish Date: May 28, 2021
Intervention Type: Procedure, Radiation, Drug
Study Drugs: FOLFIRINOX, Capecitabine
Study Phase: Phase 2
Phase II Feasibility Study of FOLFIRINOX-Losartan Followed by Accelerated Short Course Radiation Therapy With Capecitabine for Locally Advanced Pancreatic Cancer
Phase II Feasibility Study of FOLFIRINOX-Losartan Followed by Accelerated Short Course Radiation Therapy With Capecitabine for Locally Advanced Pancreatic Cancer
Enrollment Status: Unknown
Publish Date: September 25, 2020
Intervention Type: Drug, Radiation
Study Drugs: FOLFIRINOX, Losartan
Study Phase: Phase 2
Randomized Phase III Study of Focal Radiation Therapy for Unresectable, Localized Intrahepatic Cholangiocarcinoma
Randomized Phase III Study of Focal Radiation Therapy for Unresectable, Localized Intrahepatic Cholangiocarcinoma
Enrollment Status: Terminated
Publish Date: August 28, 2019
Intervention Type: Radiation
Study Phase: Phase 3
A Study of the Role of Circulating Tumor DNA in Predicting the Likelihood of Organ Preservation After Clinical Complete Response to Neoadjuvant Therapy for Rectal Cancer
A Study of the Role of Circulating Tumor DNA in Predicting the Likelihood of Organ Preservation After Clinical Complete Response to Neoadjuvant Therapy for Rectal Cancer
Enrollment Status: Withdrawn
Publish Date: July 08, 2019
Intervention Type: Other
Phase I Study of Chemoradiation With Midostaurin (PKC412) For Locally Advanced Rectal Cancer
Phase I Study of Chemoradiation With Midostaurin (PKC412) For Locally Advanced Rectal Cancer
Enrollment Status: Completed
Publish Date: December 12, 2018
Intervention Type: Drug
Study Phase: Phase 1
View 18 Less Clinical Trials

289 Total Publications

Challenges Remaining for Yttrium-90 Radioembolization: The Case for Standardized Dosimetry and Comparative Local Control Analyses in Liver Tumors.
Challenges Remaining for Yttrium-90 Radioembolization: The Case for Standardized Dosimetry and Comparative Local Control Analyses in Liver Tumors.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: October 14, 2025
View All 289 Publications
Similar Doctors
Experienced in Ewing Sarcoma
Dr. Karen C Marcus
Radiology
Experienced in Ewing Sarcoma
Dr. Karen C Marcus
Radiology

Dana-Farber Cancer Institute

450 Brookline Ave, 
Boston, MA 
 (0.2 miles away)
617-732-8783
Languages Spoken:
English
See accepted insurances

Karen C Marcus is a Radiologist in Boston, Massachusetts. Dr. C Marcus is rated as an Experienced provider by MediFind in the treatment of Ewing Sarcoma. Her top areas of expertise are Ewing Sarcoma, Primitive Neuroectodermal Tumor (PNET), Posterior Fossa Tumor, and Metastatic Brain Tumor.

Daniel Schmidt
Experienced in Ewing Sarcoma
Dr. Daniel Schmidt
Radiology
Experienced in Ewing Sarcoma
Dr. Daniel Schmidt
Radiology

Beth Israel Deaconess Medical Center

330 Brookline Avenue, Finard Basement, 
Boston, MA 
 (0.1 miles away)
617-667-2345
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Daniel Schmidt is a Radiologist in Boston, Massachusetts. Dr. Schmidt is rated as an Advanced provider by MediFind in the treatment of Ewing Sarcoma. His top areas of expertise are Bone Tumor, Familial Prostate Cancer, Melanoma, and Anal Cancer.

Daniel J. Canaday
Experienced in Ewing Sarcoma
Dr. Daniel J. Canaday
Radiology
Experienced in Ewing Sarcoma
Dr. Daniel J. Canaday
Radiology

BID Plymouth, Department Of Radiation Oncology

275 Sandwich Street, 
Plymouth, MA 
 (36.1 miles away)
508-830-2575
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Daniel Canaday is a Radiologist in Plymouth, Massachusetts. Dr. Canaday is rated as a Distinguished provider by MediFind in the treatment of Ewing Sarcoma. His top areas of expertise are Lung Cancer, Pleuropulmonary Blastoma, Small Cell Lung Cancer (SCLC), and Familial Prostate Cancer.

VIEW MORE EWING SARCOMA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Hong's expertise for a condition
ConditionClose
  • Elite
  • Anal Cancer
    Dr. Hong is
    Elite
    . Learn about Anal Cancer.
    See more Anal Cancer experts
  • Cholangiocarcinoma (Bile Duct Cancer)
    Dr. Hong is
    Elite
    . Learn about Cholangiocarcinoma (Bile Duct Cancer).
    See more Cholangiocarcinoma (Bile Duct Cancer) experts
  • Pancreatic Cancer
    Dr. Hong is
    Elite
    . Learn about Pancreatic Cancer.
    See more Pancreatic Cancer experts
  • Distinguished
  • Ampullary Cancer
    Dr. Hong is
    Distinguished
    . Learn about Ampullary Cancer.
    See more Ampullary Cancer experts
  • Familial Pancreatic Cancer
    Dr. Hong is
    Distinguished
    . Learn about Familial Pancreatic Cancer.
    See more Familial Pancreatic Cancer experts
  • Fibrolamellar Carcinoma
    Dr. Hong is
    Distinguished
    . Learn about Fibrolamellar Carcinoma.
    See more Fibrolamellar Carcinoma experts
  • Gallbladder Adenocarcinoma
    Dr. Hong is
    Distinguished
    . Learn about Gallbladder Adenocarcinoma.
    See more Gallbladder Adenocarcinoma experts
  • Gallbladder Cancer
    Dr. Hong is
    Distinguished
    . Learn about Gallbladder Cancer.
    See more Gallbladder Cancer experts
  • Gastroesophageal Junction Cancer
    Dr. Hong is
    Distinguished
    . Learn about Gastroesophageal Junction Cancer.
    See more Gastroesophageal Junction Cancer experts
View All 9 Distinguished Conditions
  • Advanced
  • ALK-Positive Non-Small Cell Lung Cancer
    Dr. Hong is
    Advanced
    . Learn about ALK-Positive Non-Small Cell Lung Cancer.
    See more ALK-Positive Non-Small Cell Lung Cancer experts
  • Breast Cancer
    Dr. Hong is
    Advanced
    . Learn about Breast Cancer.
    See more Breast Cancer experts
  • Esophageal Cancer
    Dr. Hong is
    Advanced
    . Learn about Esophageal Cancer.
    See more Esophageal Cancer experts
  • Lung Adenocarcinoma
    Dr. Hong is
    Advanced
    . Learn about Lung Adenocarcinoma.
    See more Lung Adenocarcinoma experts
  • Melanoma
    Dr. Hong is
    Advanced
    . Learn about Melanoma.
    See more Melanoma experts
  • Pancreaticoduodenectomy
    Dr. Hong is
    Advanced
    . Learn about Pancreaticoduodenectomy.
    See more Pancreaticoduodenectomy experts
View All 10 Advanced Conditions
  • Experienced
  • Colonoscopy
    Dr. Hong is
    Experienced
    . Learn about Colonoscopy.
    See more Colonoscopy experts
  • EGFR Positive Lung Cancer
    Dr. Hong is
    Experienced
    . Learn about EGFR Positive Lung Cancer.
    See more EGFR Positive Lung Cancer experts
  • Endoscopy
    Dr. Hong is
    Experienced
    . Learn about Endoscopy.
    See more Endoscopy experts
  • Ewing Sarcoma
    Dr. Hong is
    Experienced
    . Learn about Ewing Sarcoma.
    See more Ewing Sarcoma experts
  • Gallbladder Disease
    Dr. Hong is
    Experienced
    . Learn about Gallbladder Disease.
    See more Gallbladder Disease experts
  • Hepatectomy
    Dr. Hong is
    Experienced
    . Learn about Hepatectomy.
    See more Hepatectomy experts
View All 16 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.